Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS6330899B2 - - Google Patents
[go: Go Back, main page]

JPS6330899B2 - - Google Patents

Info

Publication number
JPS6330899B2
JPS6330899B2 JP11740780A JP11740780A JPS6330899B2 JP S6330899 B2 JPS6330899 B2 JP S6330899B2 JP 11740780 A JP11740780 A JP 11740780A JP 11740780 A JP11740780 A JP 11740780A JP S6330899 B2 JPS6330899 B2 JP S6330899B2
Authority
JP
Japan
Prior art keywords
group
general formula
compound
represented
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP11740780A
Other languages
Japanese (ja)
Other versions
JPS5740467A (en
Inventor
Masaaki Takami
Yoichi Ninagawa
Sukeaki Oomura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kuraray Co Ltd
Original Assignee
Kuraray Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kuraray Co Ltd filed Critical Kuraray Co Ltd
Priority to JP11740780A priority Critical patent/JPS5740467A/en
Publication of JPS5740467A publication Critical patent/JPS5740467A/en
Publication of JPS6330899B2 publication Critical patent/JPS6330899B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は新規なピラゾール酢酸類及びその製造
方法に関する。さらに詳しくは、本発明は一般式
() で示されるピラゾール酢酸類及びその製造方法に
関する。 ただし、上記一般式()においてR1は水素
原子;メチル基、エチル基、プロピル基、ブチル
基などの低級アルキル基;置換基を有していても
よいフエニル基;ナフチル基;ピリジル基;又は
メチル基、エチル基、プロピル基、ブチル基など
の低級アルキル基で置換されていてもよいピリミ
ジニル基を表わし、該置換基はフツ素原子、塩素
原子、臭素原子、ヨウ素原子などのハロゲン原
子;メチル基、エチル基、プロピル基、ブチル基
などの低級アルキル基;メトキシ基、エトキシ
基、プロポキシ基、ブトキシ基などの低級アルコ
キシ基;又はニトロ基を意味する。基−
CH2CO2R2はピラゾール環の3位又は5位に位置
する。ここに、R2は水素原子;メチル基、エチ
ル基、プロピル基、ブチル基などのアルキル基;
ビニル基、アリル基、プレニル基、ゲラニル基、
フアルネシル基などのアルケニル基;又はプロパ
ルギル基などのアルキニル基を表わす。 本発明により提供される一般式()で示され
るピラゾール酢酸類は稲のイモチ病に対して優れ
た抗菌活性を有し、またそのなかの多くの化合物
は稲のゴマハガレ病、モンガレ病、キユウリのウ
ドンコ病、タンソ病、灰色カビ病、ベト病、いん
げんの灰色カビ病、キンカク病などの各種の植物
病原菌の1又はそれ以上に対して高い抗菌活性を
示し、しかも農作物に対して薬害がなく、農園芸
用殺菌剤として有用である。 一般式()で示されるピラゾール酢酸類の代
表的な化合物を挙げると下記のとおりである。
The present invention relates to novel pyrazole acetic acids and a method for producing the same. More specifically, the present invention relates to the general formula () The present invention relates to pyrazole acetic acids represented by the formula and a method for producing the same. However, in the above general formula (), R 1 is a hydrogen atom; a lower alkyl group such as a methyl group, an ethyl group, a propyl group, a butyl group; a phenyl group that may have a substituent; a naphthyl group; a pyridyl group; Represents a pyrimidinyl group that may be substituted with a lower alkyl group such as a methyl group, ethyl group, propyl group, butyl group, and the substituent is a halogen atom such as a fluorine atom, chlorine atom, bromine atom, or iodine atom; methyl , a lower alkyl group such as an ethyl group, a propyl group, a butyl group; a lower alkoxy group such as a methoxy group, an ethoxy group, a propoxy group, a butoxy group; or a nitro group. base
CH 2 CO 2 R 2 is located at the 3rd or 5th position of the pyrazole ring. Here, R 2 is a hydrogen atom; an alkyl group such as a methyl group, ethyl group, propyl group, butyl group;
vinyl group, allyl group, prenyl group, geranyl group,
It represents an alkenyl group such as a farnesyl group; or an alkynyl group such as a propargyl group. The pyrazole acetic acids represented by the general formula () provided by the present invention have excellent antibacterial activity against rice blast disease, and many of the compounds are effective against rice blast rot, mongale disease, and cucumber root rot. It exhibits high antibacterial activity against one or more of various plant pathogenic fungi such as powdery mildew, tangy mildew, gray mold, downy mildew, gray mold of kidney beans, and kinkweed, and has no phytotoxicity to agricultural crops. It is useful as a fungicide for agriculture and horticulture. Representative compounds of pyrazole acetic acids represented by the general formula () are listed below.

【表】【table】

【表】【table】

【表】【table】

【表】 本発明によれば、一般式()で示されるピラ
ゾール酢酸類は下記の方法により製造することが
できる。すなわち、一般式() (式中、R3及びR4は同一又は異なり各々低級
アルキル基を表わす。)で示される化合物及び/
又は一般式() (式中、R3及びR4同一又は異なり各々低級ア
ルキル基を表わす。)で示される化合物と一般式
() R1NHNH2 ……() 〔式中、R1は一般式()におけると同じ意
味を有する。〕で示されるヒドラジン化合物とを
酸の存在下に反応させると一般式(′) 〔式中、R1は一般式()におけると同じ意
味を有し;−CH2CO2R3基はピラゾール環の3位
又は5位に位置し、R3は一般式()における
と同じ意味を有する。〕で示されるピラゾール酢
酸エステル類が得られ、必要に応じこれを加水分
解するか又はエステル変換することにより一般式
()で示されるピラゾール酢酸類が得られる。 上記の方法を以下に詳しく説明する。まず、一
般式()で示される化合物及び/又は一般式
()で示される化合物と一般式()で示され
るヒドラジン化合物とを酸の存在下に反応させる
ことにより一般式(′a) 〔式中、R1及びR3は一般式(′)におけると
同じ意味を有する。〕で示されるピラゾール−3
−イル酢酸エステル類及び/又は一般式(′b) 〔式中、R1及びR3は一般式(′)におけると
同じ意味を有する。〕で示されるピラゾール−5
−イル酢酸エステル類が得られる。酸としては塩
酸、硫酸、燐酸、ギ酸、酢酸、蓚酸、安息香酸、
p−トルエンスルホン酸などの無機又は有機の酸
が使用される。この反応は通常、メタノール、エ
タノールなどのアルコール類、テトラヒドロフラ
ン、1,2−ジメトキシエタンなどのエーテル
類、ベンゼン、トルエン、キシレンなどの芳香族
炭化水素、N,N−ジメチルホルムアミド、ジメ
チルスルホキサイドなどの本反応に対して不活性
な溶媒の存在下又は不存在下に室温〜150℃の温
度範囲、好ましくは50℃〜100℃の温度範囲で行
なわれる。なお、酢酸の存在下に本反応を行なう
場合には、酢酸を原料の一般式()で示される
化合物又は一般式()で示される化合物に対し
て過剰に使用することにより酢酸に溶媒としての
役割を兼ねさせてもよい。 上記の反応で得られた一般式(′a)で示さ
れるピラゾール−3−イル酢酸エステル類又は一
般式(′b)で示されるピラゾール−5−イル
酢酸エステル類は、例えば次の方法(i)〜(iii)により
容易に加水分解又はエステル変換される。 〔式中、R1及びR3は一般式(′)におけると
同じ意味を有する。〕 〔式中、R1は一般式()におけると同じ意
味を有し、R5はアルキル基、アルケニル基又は
アルキニル基を表わし、Xはハロゲン原子を表わ
す。〕 〔式中、R1及びR3は一般式(′)におけると
同じ意味を有し、R5はアルキル基、アルケニル
基又はアルキニル基を表わす。〕 すなわち、方法(i)は一般式(′a)で示され
るピラゾール−3−イル酢酸エステル類又は一般
式(′b)で示されるピラゾール−5−イル酢
酸エステル類を常法に従つて水酸化カリウム、水
酸化ナトリウムなどのアルカリの存在下に加水分
解することにより行なわれる。方法(ii)は方法(i)に
より得られた一般式(a−1)で示されるピラ
ゾール−3−イル酢酸類又は一般式(b−1)
で示されるピラゾール−5−イル酢酸類をまず常
法によりベンゼン、トルエンなどの不活性溶媒中
で塩化チオニル、臭化チオニルなどのハロゲン化
チオニルで処理してそれぞれ対応する酸ハライド
を得、ついで得られた酸ハライドに一般式R5OH
で示されるアルコールをピリジン、トリエチルア
ミンのような第3級アミンの存在下にベンゼン、
トルエンのような不活性溶媒中、室温下に反応さ
せることにより行なわれる。方法(iii)は一般式
(′a)で示されるピラゾール−3−イル酢酸エ
ステル類又は一般式(′b)で示されるピラゾ
ール−5−イル酢酸エステル類を常法に従いベン
ゼン、トルエンなどの不活性溶媒中、水酸化カリ
ウム、水酸化ナトリウムなどのアルカリの存在下
に一般式R5OHで示されるアルコールとともに加
熱撹拌し、生成する低沸点アルコールを留去する
ことにより行なわれる。 目的とするピラゾール酢酸類がピラゾール−3
−イル酢酸類とピラゾール−5−イル酢酸類との
混合物として得られる場合、この混合物を再結
晶、蒸留、クロマトグラフイーなどの通常の分離
手段に供することにより容易に個々の目的とする
ピラゾール酢酸類が得られる。 本発明に用いる一般式()で示される化合物
は1−低級アルコキシ−1−ブテン−3−インと
炭酸ジ低級アルキルエステル類とを低級アルカノ
ール中でナトリウムアルコレートの存在下に反応
させることにより得られ、また一般式()で示
される化合物は1−低級アルコキシ−1−ブテン
−3−インと炭酸ジ低級アルキルエステルとをナ
トリウムアルコレートの存在下に反応させること
により得られる〔Ber.,89,878(1956)参照〕。
一般式()で示されるヒドラジン化合物として
ヒドラジン、メチルヒドラジン、フエニルヒドラ
ジン、4−クロルフエニルヒドラジン、2,4−
ジクロルフエニルヒドラジン、4−メチルフエニ
ルヒドラジン、4−メトキシフエニルヒドラジ
ン、4−ニトロフエニルヒドラジン、β−ナフチ
ルヒドラジン、2−ピリジルヒドラジン、3−メ
チルピリミジニルヒドラジン基などを例示するこ
とができる。 以下、本発明を実施例により説明するが、本発
明はこれらの実施例によつて何ら制限を受けるも
のではない。 実施例 1 1−フエニルピラゾール−3−イル酢酸エチル
及び1−フエニルピラゾール−5−イル酢酸エ
チルの合成 エチル3,5,5−トリエトキシ−2−ペンテ
ノエート0.5g及びフエニルヒドラジン塩酸塩
0.27gをエタノール10mlに加え、30分間加熱還流
した。得られた反応液に水を加え、ついでこの溶
液をジエチルエーテルで抽出した。エーテル抽出
液をシリカゲル薄層クロマトグラフイー(溶媒:
クロロホルム)で分離精製することにより下記の
NMRスペクトルを各々有する油状の1−フエニ
ルピラゾール−3−イル酢酸エチル(化合物2)
を0.13g及び油状の1−フエニルピラゾール−5
−イル酢酸エチル(化合物1)を0.22g得た。 NMRスペクトル(CDCl3)δ: 化合物1 1.04(3H,t,J=7Hz),3.53
(2H,s), 3.93(2H,q,J=7Hz), 6.20(1H,d,J=2Hz),7.22(5H,
s), 7.43(1H,d,J=2Hz) 化合物2 1.16(3H,t,J=7Hz),3.61
(2H,s), 4.04(2H,q,J=7Hz), 6.28(1H,d,J=2Hz),7.3(5H,
m), 7.66(1H,d,J=2Hz) 実施例1と同様の方法により下記の性状を有す
る1−(3−メチルピリミジニル)ピラゾール−
5−イル酢酸エチル(化合物13)、1−(3−メチ
ルピリミジニル)ピラゾール−3−イル酢酸エチ
ル(化合物14)、1−メチルピラゾール−5−イ
ル酢酸エチル(化合物15)及び1−メチルピラゾ
ール−3−イル酢酸エチル(化合物16)を得た。
[Table] According to the present invention, pyrazole acetic acids represented by the general formula () can be produced by the following method. That is, the general formula () (In the formula, R 3 and R 4 are the same or different and each represents a lower alkyl group.)
or general formula () (In the formula, R 3 and R 4 are the same or different and each represents a lower alkyl group.) and the general formula () R 1 NHNH 2 ... () [In the formula, R 1 is the same as in the general formula ()] have the same meaning. ] When reacting with the hydrazine compound shown in the presence of an acid, the general formula (') is obtained. [In the formula, R 1 has the same meaning as in the general formula (); -CH 2 CO 2 R 3 group is located at the 3rd or 5th position of the pyrazole ring, and R 3 has the same meaning as in the general formula () have meaning. ] A pyrazole acetic acid ester represented by the general formula () is obtained, and if necessary, this is hydrolyzed or converted into an ester to obtain a pyrazole acetic acid represented by the general formula (2). The above method will be explained in detail below. First, by reacting a compound represented by the general formula () and/or a compound represented by the general formula () with a hydrazine compound represented by the general formula () in the presence of an acid, a compound represented by the general formula ('a) is obtained. [In the formula, R 1 and R 3 have the same meanings as in the general formula ('). ] Pyrazole-3
-yl acetate esters and/or general formula ('b) [In the formula, R 1 and R 3 have the same meanings as in the general formula ('). ] Pyrazole-5
-ylacetic acid esters are obtained. Acids include hydrochloric acid, sulfuric acid, phosphoric acid, formic acid, acetic acid, oxalic acid, benzoic acid,
Inorganic or organic acids such as p-toluenesulfonic acid are used. This reaction usually involves alcohols such as methanol and ethanol, ethers such as tetrahydrofuran and 1,2-dimethoxyethane, aromatic hydrocarbons such as benzene, toluene, and xylene, N,N-dimethylformamide, dimethyl sulfoxide, etc. The reaction is carried out in the presence or absence of a solvent inert to the reaction at a temperature range of room temperature to 150°C, preferably 50°C to 100°C. In addition, when carrying out this reaction in the presence of acetic acid, acetic acid is used in excess of the compound represented by the general formula () or the compound represented by the general formula () as a raw material, so that the acetic acid acts as a solvent. It may also serve as a role. The pyrazol-3-yl acetate represented by the general formula ('a) or the pyrazol-5-yl acetate represented by the general formula ('b) obtained by the above reaction can be prepared, for example, by the following method (i). ) to (iii) are easily hydrolyzed or esterified. [In the formula, R 1 and R 3 have the same meanings as in the general formula ('). ] [In the formula, R 1 has the same meaning as in the general formula (), R 5 represents an alkyl group, an alkenyl group, or an alkynyl group, and X represents a halogen atom. ] [In the formula, R 1 and R 3 have the same meanings as in general formula ('), and R 5 represents an alkyl group, an alkenyl group, or an alkynyl group. In other words, method (i) involves adding a pyrazol-3-yl acetate represented by the general formula ('a) or a pyrazol-5-yl acetate represented by the general formula ('b) to water according to a conventional method. Hydrolysis is carried out in the presence of an alkali such as potassium oxide or sodium hydroxide. Method (ii) is a pyrazol-3-yl acetic acid represented by general formula (a-1) or general formula (b-1) obtained by method (i).
The pyrazol-5-yl acetic acids represented by are first treated with a thionyl halide such as thionyl chloride or thionyl bromide in an inert solvent such as benzene or toluene by a conventional method to obtain the corresponding acid halide; The acid halide has the general formula R 5 OH
The alcohol represented by is mixed with benzene in the presence of a tertiary amine such as pyridine or triethylamine.
The reaction is carried out in an inert solvent such as toluene at room temperature. Method (iii) is to add a pyrazol-3-yl acetate represented by the general formula ('a) or a pyrazol-5-yl acetate represented by the general formula ('b) to an inorganic compound such as benzene or toluene according to a conventional method. This is carried out by heating and stirring together with an alcohol represented by the general formula R 5 OH in an active solvent in the presence of an alkali such as potassium hydroxide or sodium hydroxide, and distilling off the produced low-boiling alcohol. The target pyrazole acetic acid is pyrazole-3
When obtained as a mixture of pyrazole-5-ylacetic acids and pyrazole-5-ylacetic acids, it is easy to obtain the desired pyrazole acetic acid by subjecting this mixture to conventional separation means such as recrystallization, distillation, and chromatography. can be obtained. The compound represented by the general formula () used in the present invention can be obtained by reacting 1-lower alkoxy-1-buten-3-yne and di-lower alkyl carbonate in a lower alkanol in the presence of sodium alcoholate. The compound represented by the general formula () can be obtained by reacting 1-lower alkoxy-1-buten-3-yne and di-lower alkyl carbonate in the presence of sodium alcoholate [Ber., 89 , 878 (1956)].
Hydrazine compounds represented by the general formula () include hydrazine, methylhydrazine, phenylhydrazine, 4-chlorophenylhydrazine, 2,4-
Examples include dichlorophenylhydrazine, 4-methylphenylhydrazine, 4-methoxyphenylhydrazine, 4-nitrophenylhydrazine, β-naphthylhydrazine, 2-pyridylhydrazine, and 3-methylpyrimidinylhydrazine. EXAMPLES The present invention will be explained below with reference to Examples, but the present invention is not limited in any way by these Examples. Example 1 Synthesis of ethyl 1-phenylpyrazol-3-ylacetate and ethyl 1-phenylpyrazol-5-ylacetate 0.5 g of ethyl 3,5,5-triethoxy-2-pentenoate and phenylhydrazine hydrochloride
0.27 g was added to 10 ml of ethanol and heated under reflux for 30 minutes. Water was added to the resulting reaction solution, and then this solution was extracted with diethyl ether. The ether extract was subjected to silica gel thin layer chromatography (solvent:
By separating and purifying with chloroform), the following can be obtained.
Oily ethyl 1-phenylpyrazol-3-ylacetate (compound 2) each with an NMR spectrum
0.13g and oily 1-phenylpyrazole-5
-0.22g of ethyl acetate (compound 1) was obtained. NMR spectrum (CDCl 3 ) δ: Compound 1 1.04 (3H, t, J = 7Hz), 3.53
(2H, s), 3.93 (2H, q, J = 7Hz), 6.20 (1H, d, J = 2Hz), 7.22 (5H,
s), 7.43 (1H, d, J = 2Hz) Compound 2 1.16 (3H, t, J = 7Hz), 3.61
(2H, s), 4.04 (2H, q, J = 7Hz), 6.28 (1H, d, J = 2Hz), 7.3 (5H,
m), 7.66 (1H, d, J = 2Hz) 1-(3-methylpyrimidinyl)pyrazole- having the following properties was prepared in the same manner as in Example 1.
Ethyl 5-ylacetate (Compound 13), ethyl 1-(3-methylpyrimidinyl)pyrazol-3-ylacetate (Compound 14), ethyl 1-methylpyrazol-5-ylacetate (Compound 15) and 1-methylpyrazole- Ethyl 3-yl acetate (compound 16) was obtained.

【表】 実施例 2 1−フエニルピラゾール−3−イル酢酸エチル
及び1−フエニルピラゾール−5−イル酢酸エ
チルの合成 エチル3,5−ジエトキシ−2,4−ペンタジ
エノエート0.5g及びフエニルヒドラジン塩酸塩
0.4gをエタノール10mlに加え、20時間加熱還流
した。得られた反応液に水を加え、ついでこの溶
液を酢酸エチルで抽出した。酢酸エチル抽出液を
無水硫酸マグネシウムで乾燥し、溶媒を留去後、
その残渣をシリカゲルクロマトグラフイー(溶
媒:ベンゼン−クロロホルム)で分離精製するこ
とにより1−フエニルピラゾール−3−イル酢酸
エチル(化合物2)を0.14g及び1−フエニルピ
ラゾール−5−イル酢酸エチル(化合物1)を
0.37g得た。 実施例 3 ピラゾール−3−イル酢酸エチルの合成 エチル3,5,5−トリエトキシ−2−ペンテ
ノエート及びエチル3,5−ジエトキシ−2,4
−ペンタジエノエートの重量比3:1の混合物50
g及びヒドラジン水和物18gをエタノール200ml
に加え、この溶液に濃塩酸50mlを滴下したのち、
14時間加熱還流した。得られた反応液から溶媒を
留去後、その残渣に水を加え、さらに炭酸カリウ
ム水溶液を加えて弱アルカリ性とし、この溶液を
酢酸エチルで抽出した。酢酸エチル抽出液を無水
硫酸ナトリウムで乾燥し、溶媒を留去後、その残
渣をシリカゲルクロマトグラフイー(溶媒:ベン
ゼン−酢酸エチル)で精製することにより下記の
NMRスペクトルを有する油状のピラゾール−3
−イル酢酸エチル(化合物11)を17g得た。 NMRスペクトル(CDCl3)δ: 1.23(3H,t,J=7Hz),3.76(2H,
s), 4.15(2H,q,J=7Hz),6.24(1H,
d,J=2Hz), 7.52(1H,d,J=2Hz) 実施例3と同様の方法により下記の性状を有す
る1−(4−ニトロフエニル)ピラゾール−5−
イル酢酸エチル(化合物3)、1−(4−ニトロフ
エニル)ピラゾール−3−イル酢酸エチル(化合
物4)、1−(3,4−ジクロルフエニル)ピラゾ
ール−5−イル酢酸エチル(化合物5)及び1−
(3,4−ジクロルフエニル)ピラゾール−3−
イル酢酸エチル(化合物6)を得た。
[Table] Example 2 Synthesis of ethyl 1-phenylpyrazol-3-yl acetate and ethyl 1-phenylpyrazol-5-yl acetate 0.5 g of ethyl 3,5-diethoxy-2,4-pentadienoate and enylhydrazine hydrochloride
0.4 g was added to 10 ml of ethanol and heated under reflux for 20 hours. Water was added to the resulting reaction solution, and then this solution was extracted with ethyl acetate. The ethyl acetate extract was dried over anhydrous magnesium sulfate, and the solvent was distilled off.
The residue was separated and purified by silica gel chromatography (solvent: benzene-chloroform) to obtain 0.14 g of 1-phenylpyrazol-3-yl ethyl acetate (compound 2) and 1-phenylpyrazol-5-yl ethyl acetate. (Compound 1)
Obtained 0.37g. Example 3 Synthesis of ethyl pyrazol-3-ylacetate Ethyl 3,5,5-triethoxy-2-pentenoate and ethyl 3,5-diethoxy-2,4
- a mixture of pentadienoates in a weight ratio of 3:1 50
g and 18 g of hydrazine hydrate in 200 ml of ethanol.
In addition, 50 ml of concentrated hydrochloric acid was added dropwise to this solution, and then
The mixture was heated under reflux for 14 hours. After distilling off the solvent from the resulting reaction solution, water was added to the residue, and an aqueous potassium carbonate solution was further added to make it slightly alkaline, and this solution was extracted with ethyl acetate. The ethyl acetate extract was dried over anhydrous sodium sulfate, the solvent was distilled off, and the residue was purified by silica gel chromatography (solvent: benzene-ethyl acetate) to obtain the following.
Oily pyrazole-3 with NMR spectrum
17 g of ethyl -ylacetate (compound 11) was obtained. NMR spectrum (CDCl 3 ) δ: 1.23 (3H, t, J = 7Hz), 3.76 (2H,
s), 4.15 (2H, q, J=7Hz), 6.24 (1H,
d, J = 2Hz), 7.52 (1H, d, J = 2Hz) 1-(4-nitrophenyl)pyrazole-5- having the following properties was prepared in the same manner as in Example 3.
Ethyl ylacetate (Compound 3), ethyl 1-(4-nitrophenyl)pyrazol-3-ylacetate (Compound 4), ethyl 1-(3,4-dichlorophenyl)pyrazol-5-ylacetate (Compound 5) and 1-
(3,4-dichlorophenyl)pyrazole-3-
Ethyl yl acetate (compound 6) was obtained.

【表】 実施例 4 1−フエニルピラゾール−5−イル酢酸の合成 1−フエニルピラゾール−5−イル酢酸エチル
(化合物1)3g及び水酸化ナトリウム1gをエ
タノール50ml及び水5mlの混合溶液に加え、室温
で一夜撹拌した。得られた反応液に水100mlを加
え、ついでこの溶液をジエチルエーテルで洗滌し
た。水層に希塩酸を加えて酸性とし、この溶液を
クロロホルムで抽出した。クロロホルム抽出液か
ら溶媒を留去後、その残渣をベンゼン−n−ヘキ
サン混合溶液で再結晶することにより下記の性状
を有する1−フエニルピラゾール−5−イル酢酸
(化合物7)を2.3g得た。 化合物7 mp.105〜106℃ NMR(アセトン−d6)δ:3.72(2H,
s), 6.31(1H,d,J=2Hz), 7.46(5H,s), 7.51(1H,d,J=2Hz) 実施例4と同様の方法により下記の性状を有す
る1−フエニルピラゾール−3−イル酢酸(化合
物8)、1−(3,4−ジクロルフエニル)ピラゾ
ール−5−イル酢酸(化合物9)及び1−(3−
メチルピリミジニル)ピラゾール−3−イル酢酸
(化合物10)を得た。 化合物8 mp.73〜75℃ NMR(アセトン−d6)δ:3.60(2H,
s), 6.35(1H,d,J=2Hz), 7.2(3H,m),7.66(2H,m), 8.05(1H,d,J=2Hz) 化合物9 mp.156℃ NMR(アセトン−d6)δ:3.76(2H,
s), 6.34(1H,d,J=2Hz), 7.5(3H,m), 7.65(1H,d,J=2Hz) 化合物10 mp.169〜170℃ NMR(DMSO−d6)δ:2.41(3H,s,)
3.60(2H,s), 6.41(1H,d,J=2Hz), 7.19(1H,d,J=5Hz), 8.44(1H,d,J=2Hz), 実施例 5 ピラゾール−3−イル酢酸ゲラニルの合成 ピラゾール−3−イル酢酸エチル(化合物11)
23g、ゲラニオール66g及び水酸化カリウム0.2
gをトルエン300mlに加え、生成するエタノール
をトルエンとともに留去させながら加熱撹拌を続
けた。1時間後、反応液にさらに水酸化カリウム
0.2gを加え、2時間加熱撹拌を続けた。放冷に
より得られた反応液の温度を室温にし、この反応
液にジエチルエーテル300mlを加え、水洗した。
有機層を濃縮し、ゲラニオールを留去させたの
ち、その残渣をシリカゲルクロマトグラフイー
(溶媒:ベンゼン)で分離精製することにより下
記のNMRスペクトルを有する油状のピラゾール
−3−イル酢酸ゲラニル(化合物12)を28g得
た。 NMRスペクトル(CDCl3)δ: 1.55(3H,s),1.62(6H,s),2.0(4H,m), 3.70(2H,s),4.59(2H,d,J=7Hz), 5.03(1H,m),5.30(1H,t,J=7Hz), 6.19(1H,d,J=2Hz),7.47(1H,d,J=
2Hz)。
[Table] Example 4 Synthesis of 1-phenylpyrazol-5-ylacetic acid 3 g of ethyl 1-phenylpyrazol-5-ylacetate (compound 1) and 1 g of sodium hydroxide were added to a mixed solution of 50 ml of ethanol and 5 ml of water. and stirred at room temperature overnight. 100 ml of water was added to the resulting reaction solution, and then this solution was washed with diethyl ether. Dilute hydrochloric acid was added to the aqueous layer to make it acidic, and this solution was extracted with chloroform. After distilling off the solvent from the chloroform extract, the residue was recrystallized with a benzene-n-hexane mixed solution to obtain 2.3 g of 1-phenylpyrazol-5-yl acetic acid (compound 7) having the following properties. . Compound 7 mp.105-106℃ NMR (acetone-d6) δ: 3.72 (2H,
s), 6.31 (1H, d, J = 2Hz), 7.46 (5H, s), 7.51 (1H, d, J = 2Hz) 1-Phenylpyrazole- having the following properties was prepared in the same manner as in Example 4. 3-yl acetic acid (compound 8), 1-(3,4-dichlorophenyl)pyrazol-5-yl acetic acid (compound 9) and 1-(3-
Methylpyrimidinyl)pyrazol-3-yl acetic acid (compound 10) was obtained. Compound 8 mp.73-75℃ NMR (acetone-d6) δ: 3.60 (2H,
s), 6.35 (1H, d, J = 2Hz), 7.2 (3H, m), 7.66 (2H, m), 8.05 (1H, d, J = 2Hz) Compound 9 mp.156℃ NMR (acetone-d6) δ: 3.76 (2H,
s), 6.34 (1H, d, J = 2Hz), 7.5 (3H, m), 7.65 (1H, d, J = 2Hz) Compound 10 mp.169-170℃ NMR (DMSO-d6) δ: 2.41 (3H ,s,)
3.60 (2H, s), 6.41 (1H, d, J = 2Hz), 7.19 (1H, d, J = 5Hz), 8.44 (1H, d, J = 2Hz), Example 5 Pyrazol-3-ylgeranyl acetate Synthesis of ethyl pyrazol-3-yl acetate (compound 11)
23g, geraniol 66g and potassium hydroxide 0.2
g was added to 300 ml of toluene, and heating and stirring were continued while the produced ethanol was distilled off together with the toluene. After 1 hour, add potassium hydroxide to the reaction solution.
0.2 g was added, and heating and stirring were continued for 2 hours. The temperature of the reaction solution obtained by cooling was brought to room temperature, and 300 ml of diethyl ether was added to the reaction solution, followed by washing with water.
After concentrating the organic layer and distilling off geraniol, the residue was separated and purified using silica gel chromatography (solvent: benzene) to obtain an oily pyrazol-3-ylgeranyl acetate (compound 12) having the following NMR spectrum. ) was obtained. NMR spectrum (CDCl 3 ) δ: 1.55 (3H, s), 1.62 (6H, s), 2.0 (4H, m), 3.70 (2H, s), 4.59 (2H, d, J=7Hz), 5.03 (1H , m), 5.30 (1H, t, J = 7Hz), 6.19 (1H, d, J = 2Hz), 7.47 (1H, d, J =
2Hz).

Claims (1)

【特許請求の範囲】 1 一般式() (式中、R1は水素原子、低級アルキル基、置
換基を有していてもよいフエニル基、ナフチル
基、ピリジル基又は低級アルキル基で置換されて
いてもよいピリミジニル基を表わし、該置換基は
ハロゲン原子、低級アルキル基、低級アルコキシ
基又はニトロ基を意味し;−CH2CO2R2基はピラ
ゾール環の3位又は5位に位置し、R2は水素原
子、アルキル基、アルケニル基又はアルキニル基
を表わす。) で示されるピラゾール酢酸類。 2 一般式() で示される化合物及び/又は一般式() で示される化合物と一般式() R1NHNH2 ……() で示されるヒドラジン化合物とを酸の存在下に反
応させることにより一般式(′) で示されるピラゾール酢酸類を得、必要に応じこ
れを加水分解するか又はエステル変換することを
特徴とする一般式() で示されるピラゾール酢酸類の製造方法。 (上記式中、R1は水素原子、低級アルキル基、
置換基を有していてもよいフエニル基、ナフチル
基、ピリジル基又は低級アルキル基で置換されて
いてもよいピリミジニル基を表わし、該置換基は
ハロゲン原子、低級アルキル基、低級アルコキシ
基又はニトロ基を意味し;−CH2CO2R2基はピラ
ゾール環の3位又は5位に位置し、R2は水素原
子、アルキル基、アルケニル基又はアルキニル基
を表わし;−CH2CO2R3基はピラゾール環の3位
又は5位に位置し;R3及びR4は同一又は異なり
各々低級アルキル基を表わす。)
[Claims] 1 General formula () (In the formula, R 1 represents a hydrogen atom, a lower alkyl group, a phenyl group that may have a substituent, a naphthyl group, a pyridyl group, or a pyrimidinyl group that may be substituted with a lower alkyl group, and the substituent means a halogen atom, a lower alkyl group, a lower alkoxy group, or a nitro group; -CH 2 CO 2 R 2 group is located at the 3rd or 5th position of the pyrazole ring, and R 2 is a hydrogen atom, an alkyl group, an alkenyl group or represents an alkynyl group.) Pyrazole acetic acids represented by: 2 General formula () Compound and/or general formula () represented by By reacting the compound represented by the general formula () with the hydrazine compound represented by the general formula () R 1 NHNH 2 ...() in the presence of an acid, the general formula (') is obtained. A general formula () characterized by obtaining a pyrazole acetic acid represented by and optionally hydrolyzing or converting it into an ester A method for producing pyrazole acetic acids represented by (In the above formula, R 1 is a hydrogen atom, a lower alkyl group,
Represents a phenyl group, naphthyl group, pyridyl group, or pyrimidinyl group optionally substituted with a lower alkyl group, which may have a substituent, and the substituent is a halogen atom, a lower alkyl group, a lower alkoxy group, or a nitro group. -CH 2 CO 2 R 2 group is located at the 3rd or 5th position of the pyrazole ring, R 2 represents a hydrogen atom, an alkyl group, an alkenyl group or an alkynyl group; -CH 2 CO 2 R 3 group is located at the 3rd or 5th position of the pyrazole ring; R 3 and R 4 are the same or different and each represents a lower alkyl group. )
JP11740780A 1980-08-25 1980-08-25 Pyrazoleacetic acid and its preparation Granted JPS5740467A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11740780A JPS5740467A (en) 1980-08-25 1980-08-25 Pyrazoleacetic acid and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11740780A JPS5740467A (en) 1980-08-25 1980-08-25 Pyrazoleacetic acid and its preparation

Publications (2)

Publication Number Publication Date
JPS5740467A JPS5740467A (en) 1982-03-06
JPS6330899B2 true JPS6330899B2 (en) 1988-06-21

Family

ID=14710876

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11740780A Granted JPS5740467A (en) 1980-08-25 1980-08-25 Pyrazoleacetic acid and its preparation

Country Status (1)

Country Link
JP (1) JPS5740467A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001158704A (en) * 1999-09-24 2001-06-12 Mitsubishi Chemicals Corp Insecticide, acaricide

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1226387B (en) * 1988-07-08 1991-01-15 Seuref Ag PROCESS FOR THE PREPARATION OF 1,4-DIARYL-3-PYRAZOL-ACETIC ACIDS
AU7319100A (en) 1999-09-24 2001-04-24 Agro-Kanesho Co. Ltd. Insecticidal and acaricidal agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001158704A (en) * 1999-09-24 2001-06-12 Mitsubishi Chemicals Corp Insecticide, acaricide

Also Published As

Publication number Publication date
JPS5740467A (en) 1982-03-06

Similar Documents

Publication Publication Date Title
EP0791571B1 (en) Benzoyl derivatives
JP3921238B2 (en) Benzoyl derivatives and their synthesis
JPS6330899B2 (en)
WO2006021652A1 (en) Method for preparing n-piperidino-1,5-diphenylpyrazole-3-carboxamide derivatives
NO165104B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1, 1-DISUBSTITUTED CYCLOPROPANDER DERIVATIVES.
JPH07116158B2 (en) Method for producing cyclopentane derivative
US5869684A (en) Method for producing pyrazolinone compounds
JP4727576B2 (en) Process for preparing alkyl esters of difluoroacetoacetic acid
US6211387B1 (en) Diol compounds as intermediates for preparing antimycotic compounds
EP0220025B1 (en) 3-perfluoroalkyl-5-hydroxyisoxazoles
JPH0468309B2 (en)
JP2001342178A (en) Method for producing 4-methylpyrazole-5-carboxylic acid
JP3491344B2 (en) Method for producing 1-alkyl-5-pyrazolecarboxylic acid esters
JPH06199805A (en) Production of @(3754/24)3-substituted phenyl)pyrazole derivative
JPS649317B2 (en)
JPH01168675A (en) Production of 1,3-dialkylpyrazole-5-carboxylic acid esters
JP3116171B2 (en) Method for producing pyrazole derivative, intermediate thereof, and method for producing the same
US5925795A (en) Processes for the preparation of aryl-β-diketones, arylpyrimidine ketones and crop protection intermediates
US4539160A (en) Ketene O,O-acetals and their preparation
US2973367A (en) Novel pyrazole carbinols
EP1753726B1 (en) Method for producing 1,5-diphenylpyrazole carboxylic acid derivatives
JP2743441B2 (en) Cyclopenta [1,2-C] -3-pyrazolecarboxylic acid derivative
US4377532A (en) 3-Phenoxybenzyl compounds
WO1997047608A1 (en) Process for producing 2-(1h-1,2,4-triazol-1-yl)acetophenones
JPH023787B2 (en)